Xiansi Zhao

618 citations
10 papers · 440 indexed · h-index 8
Topics
interferon and immune responses (2 papers)RNA modifications and cancer (2 papers)Retinoids in leukemia and cellular processes (2 papers)
Partner nations
United States

In The Last Decade

Xiansi Zhao

10 papers receiving 431 citations

Peers

Xiansi Zhao
Comparison fields: 5 of 67
  • Molecular Biology 344
  • Cancer Research 117
  • Oncology 77
  • Genetics 67
  • Immunology 50
Replace Mohini A. Patil with:
Mohini A. Patil United States
Karla J. Posekany United States
Paola Costanzo Italy
Yeo-Jin Jeon South Korea
Sylvie Michelland France
Laura Bachelot France
Victoria Izumi United States
Núria Bonifaci Spain
Shirong Yu China
Aram Ko South Korea
Xiansi Zhao relative to Mohini A. Patil United States Mohini A. Patil's profile →
Citations per field
00.5×1.5×2.4×
Mohini A. Patil · 1×
Citations per year

Countries citing papers authored by Xiansi Zhao

Since Specialization
Citations

This map shows the geographic impact of Xiansi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiansi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiansi Zhao more than expected).

Fields of papers citing papers by Xiansi Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiansi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiansi Zhao. The network helps show where Xiansi Zhao may publish in the future.

Co-authorship network of co-authors of Xiansi Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiansi Zhao. A scholar is included among the top collaborators of Xiansi Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiansi Zhao. Xiansi Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 6
2 5
3 82
4 23
5
Evaluation of 19-nor-2alpha-(3-hydroxypropyl)-1alpha,25-dihydroxyvitamin D3 as a therapeutic agent for androgen-dependent prostate cancer.
44
6 57
7 18
8 55
9 118
10 32

About Xiansi Zhao

Xiansi Zhao is a scholar working on Cell Biology, Immunology and Cancer Research, having authored 10 papers that have together received 440 indexed citations. Recurring topics across this work include interferon and immune responses (2 papers), RNA modifications and cancer (2 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Cancer Research (117 citations), Molecular Biology (344 citations) and Oncology (77 citations). Xiansi Zhao has collaborated with scholars based in United States. Frequent co-authors include Remco A. Spanjaard, Jeffrey R. Patton, Brian Florence, David E. Fisher, Akinori Kawakami, Ling Shen, Juying Li, Brian P. Fiske, Sajal K. Ghosh and Nathan Fischel‐Ghodsian. Their work appears in journals such as Nature Communications, Molecular Cell and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026